A novel MRI radiomics technique has been developed to predict survival outcomes in isocitrate dehydrogenase wild type glioblastoma (IDH-wt GBM), a highly aggressive brain tumor. Published in BMC Cancer, this method analyzes complex imaging features to provide more accurate and individualized prognosis compared to traditional clinical factors. The advancement offers a non-invasive tool to better stratify patients and potentially guide treatment decisions in this challenging cancer subtype.